Előrehaladott és metasztatikus prosztatarák: ESMO klinikai gyakorlati irányelv a diagnózishoz, a kezeléshez és a követéshez

Fizazi K (1, 2), Attard G (3), Azad AA (4), Baciarello G (5), Beltran H (6), Bjartell A (7), Blanchard P (8), Bossaert F (9), Castro E (10), Compérat E (11), de Bono J (12), Deschamps A (13), Efstathiou E (14), Emmett L (15), Fanti S (16), Fonteyne V (17), González-del-Alba A (18), Gravis G (19), James ND (20), Kanesvaran R (21), McDermott RS (22), Mehra N (23), Parker C (24), Renard-Penna RM (25), Rubin MA (26), Saad F (27), Sweeney C (28), Tilki D (29, 30, 31), Tombal B (32), Tree AC (12, 33), Walz J (34), Zilli T (35, 36), Gillessen S (36, 37), az ESMO Irányelvek Bizottsága nevében
(1) Department of Medical Oncology, Centre Oscar Lambret, Lille
(2) Department of Medical Oncology, University of Paris Saclay, Villejuif, France
(3) Research Department of Oncology, University College London, London, UK
(4) Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
(5) Department of Medical Oncology, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy
(6) Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA
(7) Department of Urology, Skåne University Hospital, Malmo, Sweden
(8) Department of Radiation Oncology, Gustave Roussy, Université Paris Saclay, INSERM U1018 Oncostat, Villejuif
(9) CerHom, Villejuif, France
(10) Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain
(11) Department of Pathology, Medical University of Vienna, Vienna, Austria
(12) Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK
(13) Europa Uomo, The European Prostate Cancer Coalition, Antwerp, Belgium
(14) Knight Comprehensive Cancer Center, Oregon Health and Science University, Portland, USA
(15) Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, Australia
(16) Department of Nuclear Medicine, IRCCS AOU di Bologna, Bologna, Italy
(17) Department of Radiation Oncology, Ghent University, Ghent, Belgium
(18) Medical Oncology Department, University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
(19) Department of Medical Oncology, Immunity and Cancer Team, Institut Paoli-Calmettes, INSERM, CNRS, CRCM, Aix Marseille University, Marseille, France
(20) Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK
(21) Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
(22) Department of Medical Oncology, St Vincent’s University Hospital & University College Dublin, Dublin, Ireland
(23) Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
(24) Urology Unit, The Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK
(25) Department of Imagery, Hôpital Pitié Salpétrière, Sorbonne Université, Paris, France
(26) Department for Biomedical Research, University of Bern, Bern, Switzerland
(27) Department of Surgery and Urologic Oncology, Centre Hospitalier de l’Université de Montréal, Université de Montréal, Montreal, Canada
(28) South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia
(29) Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg
(30) Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
(31) Department of Urology, Koc University Hospital, Istanbul, Turkey
(32) Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
(33) Uro-Oncology Department, The Royal Marsden Hospital, Sutton, UK
(34) Department of Urology, Institut Paoli-Calmettes Cancer Center, Marseille, France
(35) Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona
(36) Faculty of Biomedical Sciences, Università della Svizzera Italian, Lugano
(37) Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland